GlassScriptPhysician profile
Renata Marquez
NPI 1710646351
$1,424.17
in general payments reported to CMS, 2019-2025
13 companies · $403 in 2025
The $403 reported for 2025 was more than what 93% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.00 · 2022: $475 · 2023: $458 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $246.92 | 2025 | |
| Organon LLC | $136.93 | 2025 | |
| Sumitomo Pharma America, INC. | $124.99 | 2023 | Gemtesa |
| Abbvie INC. | $123.73 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.07 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $119.95 | 2022 | |
| Abiomed | $118.55 | 2023 | Impella |
| Si-Bone, INC. | $109.52 | 2022 | |
| Edwards Lifesciences Corporation | $109.33 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Agile Therapeutics, INC. | $88.00 | 2021 | |
| Medicem INC. | $64.58 | 2023 | |
| Coloplast Corp | $40.35 | 2023 | Altis |
| Evofem Biosciences, INC. | $19.25 | 2025 | Phexxi, Solosec, Phexx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renata Marquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.